CICONTE, GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 1.207
NA - Nord America 796
EU - Europa 563
SA - Sud America 324
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.920
Nazione #
US - Stati Uniti d'America 745
SG - Singapore 543
CN - Cina 302
BR - Brasile 281
HK - Hong Kong 169
IT - Italia 153
SE - Svezia 126
VN - Vietnam 96
DE - Germania 70
RU - Federazione Russa 46
GB - Regno Unito 37
FI - Finlandia 35
CA - Canada 27
AR - Argentina 19
AT - Austria 19
MX - Messico 19
JP - Giappone 17
BD - Bangladesh 16
PL - Polonia 16
IN - India 14
NL - Olanda 14
ZA - Sudafrica 13
EC - Ecuador 10
ID - Indonesia 10
IE - Irlanda 10
TR - Turchia 10
LT - Lituania 9
BE - Belgio 7
ES - Italia 6
FR - Francia 6
OM - Oman 6
MA - Marocco 4
SA - Arabia Saudita 4
EG - Egitto 3
EU - Europa 3
IQ - Iraq 3
KE - Kenya 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IR - Iran 2
NP - Nepal 2
PK - Pakistan 2
SN - Senegal 2
UA - Ucraina 2
VE - Venezuela 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
IM - Isola di Man 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.920
Città #
Singapore 243
Hong Kong 169
Dallas 150
Ashburn 128
Shanghai 78
Hefei 66
Milan 59
Beijing 57
Lawrence 46
Princeton 45
Ho Chi Minh City 39
New York 34
São Paulo 28
Los Angeles 25
Helsinki 21
Hanoi 17
Nuremberg 15
Warsaw 15
London 14
Tokyo 14
Boardman 13
Rome 13
Moscow 12
Vienna 12
Cesano Boscone 11
Phoenix 11
Denver 10
Dublin 10
Frankfurt am Main 10
Montreal 10
Santa Clara 10
Toronto 10
Seattle 9
Amsterdam 8
Haiphong 8
Munich 8
Stockholm 8
Ankara 7
Atlanta 7
Brasília 7
Brescia 7
Brooklyn 7
Chennai 7
Falkenstein 7
Johannesburg 7
San Francisco 7
Turku 7
Biên Hòa 6
Lappeenranta 6
Orem 6
Rio de Janeiro 6
Belo Horizonte 5
Chicago 5
Curitiba 5
Ferrara 5
Kassel 5
Manchester 5
Mexico City 5
Poplar 5
Recife 5
Salvador 5
Viareggio 5
Wolfhagen 5
Brussels 4
City of London 4
Goiânia 4
Guarulhos 4
Muscat 4
Quito 4
San Jose 4
The Dalles 4
Vilnius 4
Aracaju 3
Campinas 3
Da Nang 3
Dammam 3
Diadema 3
Guangzhou 3
Houston 3
Irecê 3
Itaquaquecetuba 3
Jackson 3
Juneau 3
Lisbon 3
Nairobi 3
Naples 3
Osasco 3
Palhoça 3
Porto Alegre 3
Pune 3
Santo André 3
Segrate 3
Sorocaba 3
Alegrete 2
Antwerp 2
Arapiraca 2
Assago 2
Asunción 2
Baku 2
Bauru 2
Totale 1.703
Nome #
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 80
Brugada syndrome genetics is associated with phenotype severity 78
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 77
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 77
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 72
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 70
HIF-1α Directly Controls WNT7A Expression During Myogenesis 70
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 68
Brugada Syndrome: Warning of a Systemic Condition? 67
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 64
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 61
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 60
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 60
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 60
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 59
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients 56
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 56
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 55
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 54
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 53
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 52
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 52
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 51
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 50
Brugada Syndrome: Oligogenic or Mendelian Disease? 50
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 49
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 48
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 46
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 45
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 45
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 44
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 43
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 43
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 43
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique 42
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 42
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 42
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 42
Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support 41
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 40
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 40
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 39
Regenerating the human heart : direct reprogramming strategies and their current limitations 39
Atrial fibrillation progression and management: a 5-year prospective follow-up study 39
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 39
Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene 39
Thrombosis on a left atrial appendage occluder device: The double-edged sword of stroke prevention strategies in atrial fibrillation 38
General Anesthesia Attenuates Brugada Syndrome Phenotype Expression: Clinical Implications From a Prospective Clinical Trial 37
Deep learning unmasks the ECG signature of Brugada syndrome 36
Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies 36
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 35
The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children 35
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance 35
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 34
Epicardial arrhythmogenic substrate in long QT syndrome 33
Safety and feasibility of a novel multielectrode array catheter in mapping atrial and ventricular arrhythmias with high density: results from the multicenter OPTIMUM study 33
Novel CineECG Derived from Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients with Brugada Syndrome 33
Congenital coronary artery anomalies: Differential diagnosis of ventricular arrhythmias in young athletes 31
Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique 29
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value 28
Reversine: A Synthetic Purine with a Dual Activity as a Cell Dedifferentiating Agent and a Selective Anticancer Drug 28
The role of implantable cardiac monitors in atrial fibrillation management 27
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry 27
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy? 25
Epicardial ablation in genetic cardiomyopathies: A new frontier 22
Totale 3.044
Categoria #
all - tutte 21.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 1 1 7 1 0 0 0
2021/202236 0 0 0 12 0 1 15 1 6 0 0 1
2022/2023264 112 49 15 7 2 34 10 8 20 5 2 0
2023/2024155 2 4 14 44 12 14 5 15 0 6 13 26
2024/20251.067 140 47 7 34 58 75 126 124 164 124 64 104
2025/20261.472 203 251 239 461 266 52 0 0 0 0 0 0
Totale 3.044